当前位置:
X-MOL 学术
›
Fam. Cancer
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Questioning the validity of clinically available breast cancer polygenic risk scores: comparison of two labs reveals discrepancies.
Familial Cancer ( IF 1.8 ) Pub Date : 2021-05-18 , DOI: 10.1007/s10689-021-00260-2 Julia Wynn 1 , Elana Levinson 2 , Carrie Koval 2 , Michelle E Ernst 3 , Wendy K Chung 1, 2
中文翻译:
质疑临床可用的乳腺癌多基因风险评分的有效性:两个实验室的比较揭示了差异。
更新日期:2021-05-18
Familial Cancer ( IF 1.8 ) Pub Date : 2021-05-18 , DOI: 10.1007/s10689-021-00260-2 Julia Wynn 1 , Elana Levinson 2 , Carrie Koval 2 , Michelle E Ernst 3 , Wendy K Chung 1, 2
Affiliation
中文翻译:
质疑临床可用的乳腺癌多基因风险评分的有效性:两个实验室的比较揭示了差异。